TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · Chief Research Officer ROTE WILLIAM E. sold 209.05K shares at $62.83/share ($13.1M); exercised options for 383K shares

Chief Research Officer ROTE WILLIAM E. sold 209.05K shares at $62.83/share ($13.1M); exercised options for 383K shares

xslF345X06/form4-09182026_010952.xml

xslF345X06/form4-09182026_010952.xmlSEC.gov

Graphics and non-inline formats (not embedded below).